• HRT Financial LP exited its stake in Shuttle Pharmaceuticals Holdings, selling 83,149 common shares in two trades on July 13-14.
• Shares sold at USD 4.67 and USD 4.48, cutting beneficial ownership to 0 from 60,238 shares.
• The filing shows HRT Financial was previously a 10% owner.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001475597-26-000159), on July 15, 2026, and is solely responsible for the information contained therein.